Earnings one week ago: 16 Aug 2017
MIGDAL HAEMEQ, Israel (AP) _ Enzymotec Ltd. (ENZY) on Wednesday reported a second-quarter loss of $2.3 million, after reporting a profit in the same period a year earlier.
On a per-share basis, the Migdal Haemeq, Israel-based company said it had a loss of 10 cents. Losses, adjusted for stock option expense, came to 6 cents per share.
The maker of lipid-based nutritional ingredients and medical foods posted revenue of $13 million in the period.
Enzymotec shares have climbed 57 percent since the beginning of the year. The stock has risen 30 percent in the last 12 months.
No comments:
Post a Comment